In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
105 News Items found
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Pictured: Craig Thompson
Perspective
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Marcia Levine
An Unplanned Path to Nursing Leadership at MSK

Marcia Levine didn’t grow up wanting to be a nurse. It’s a career that found her, providing a direction for the desire she always had to help, to fix things, to care for others.
An illustration
Feature
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
Elaine sitting down on a mountain with her border collie between her legs
MSK Nurse Exemplifies Tradition of Filipino Nursing in America

Elaine Mosqueda has traveled far in so many ways since moving from the Philippines to the United States at the age of 21.
MSK radiation oncologist Christopher Barker
Clinical Update
Advanced Basal Cell Carcinoma Responds to Combination Drug-Radiation Treatment

Learn how advanced basal cell carcinoma can be treated with a new combination radiation and drug therapy.
An illustration of sugar pouring onto NRF2
Finding
Sugar Directly Controls a Cancer-Causing Protein, Scientists Find

The discovery suggests a potential new treatment approach for certain cancers.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Alexander Drilon, MD
Precision Medicine Advances: Pivotal Studies Led by MSK Published in the New England Journal of Medicine

Following an approval from the FDA in May 2020, the New England Journal of Medicine has published data from the phase I/II LIBRETTO-001 clinical trial of selpercatinib in advanced RET (REarranged during Transfection)-driven lung and thyroid cancers. MSK’s Alexander Drilon, MD, the recently appointed Chief of the Early Drug Development Service, serves as the lead investigator for multi-site clinical trial.
Physician-scientist Alex Kentsis
In the Lab
Research Shows How Common Feature of Blood Cancers Can Be Targeted

Research points to the role of a protein called MYB, which has long been known to play a role in cancer.